Author:
Zhang Xun,Luo Mingpeng,Zhang Jiahang,Guo Bize,Singh Shreya,Lin Xixi,Xiong Hanchu,Ju Siwei,Wang Linbo,Zhou Yulu,Zhou Jichun
Abstract
Systemic therapy is one of the most significant cancer treatments. However, drug resistance often appears and has become the primary cause of cancer therapy failure. Regulation of drug target, drug metabolism and drug efflux, cell death escape (apoptosis, autophagy, et al.), epigenetic changes, and many other variables are complicatedly involved in the mechanisms of drug resistance. In various types of cancers, long non-coding RNA H19 (lncRNA H19) has been shown to play critical roles in tumor development, proliferation, metastasis, and multiple drug resistance as well. The efficacy of chemotherapy, endocrine therapy, and targeted therapy are all influenced by the expression of H19, especially in breast cancer, liver cancer, lung cancer and colorectal cancer. Here, we summarize the relationship between lncRNA H19 and tumorigenesis, and illustrate the drug resistance mechanisms caused by lncRNA H19 as well. This review may provide more therapeutic potential targets for future cancer treatments.
Funder
National Natural Science Foundation of China
Subject
Genetics (clinical),Genetics,Molecular Medicine
Reference163 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials;Abe;Lancet,2005
2. Development of targeted therapy for a broad spectrum of cancers (pancreatic cancer, ovarian cancer, glioblastoma and HCC) mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences;Amit;Int. J. Clin. Exp. Med.,2012
3. The role of long non-coding RNAs in genome formatting and expression;Angrand;Front. Genet.,2015
4. Imprinted H19 gene expression in embryogenesis and human cancer : The oncofetal connection;Ariel;Am. J. Med. Genet.,2000
5. The imprinted H19 gene as a tumor marker in bladder carcinoma;Ariel;Urology,1995
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献